SCHEMBL19545003

SCHEMBL19545003

c1ccc2c(c1)[nH]c1ccc(Nc3ccc4oc5ccccc5c4c3)cc12

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.49
KMT2A Q03164 4/20 0.49
MTNR1A P48039 1/20 0.49
MTNR1B P49286 1/20 0.49
AHR P35869 2/20 0.46
KIF11 P52732 4/20 0.44
ALDH1A1 P00352 4/20 0.44
MEN1 O00255 3/20 0.44
MAPT P10636 3/20 0.44
HPGD P15428 3/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD17B10 Q99714 2/20 0.42
GPR3 P46089 1/20 0.42
CYP1A2 P05177 1/20 0.40
NPY5R Q15761 1/20 0.39
P2RY12 Q9H244 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16366150 0.89 CASP3 (0.42) KDM4EKMT2AMTNR1AMTNR1BAHR
SCHEMBL30363422 0.85 MAPT (0.57) KDM4EKMT2AAHRALDH1A1MEN1
SCHEMBL2785067 0.85 MAPT (0.57) KDM4EKMT2AAHRALDH1A1MEN1
SCHEMBL21368343 0.84 KDM4E (0.60) KDM4EKMT2AMTNR1AMTNR1BAHR
SCHEMBL2698477 0.83 AHR (0.50) KDM4EKMT2AAHRKIF11ALDH1A1
SCHEMBL29506371 0.83 AHR (0.50) KDM4EKMT2AAHRKIF11ALDH1A1
SCHEMBL29720801 0.83 AHR (0.50) KDM4EKMT2AAHRKIF11ALDH1A1
Diphenylamine SCHEMBL28138166 0.82 ALDH1A1 (0.50) KDM4EAHRALDH1A1MAPTHPGD
SCHEMBL25012052 0.82 MEN1 (0.53) KDM4EKMT2AAHRALDH1A1MEN1
SCHEMBL16500873 0.81 AHR (0.48) KDM4EKMT2AAHRKIF11ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170317289-A1 ORGANIC ELECTRONIC DEVICE AND DISPLAY APPARATUS USING COMPOSITION FOR ORGANIC ELECTRONIC DEVICE DUK SAN NEOLUX CO., LTD. (KR) 2017-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170317289-A1 ORGANIC ELECTRONIC DEVICE AND DISPLAY APPARATUS USING COMPOSITION FOR ORGANIC ELECTRONIC DEVICE OCIAD2, OCIAD1, EPHA4 KDM4E 2905/4885KMT2A 2502/4885MTNR1A 4595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.